Grant: CIHR Fellowship
Direct Payment
$150,000.00
Wnt regulation of the hematopoietic stem cell niche
FY 2013-14
Summary
Currently, blood disorders such as leukemias and lymphomas are most easily treated with a bone marrow donation. This process is painful and the supply of donors far exceeds the demand. In fact, two-thirds of patients in need of donation do not have a match. Therefore, the ability to make blood from patient-derived stem cells would be an important advance in therapeutic technology.
Zebrafish are a particularly useful model system to watch blood form, because they are translucent and we can track the blood as it forms. In fact, we have genetic tools where we mark the blood stem cells with a fluorescent protein and we can watch the stem cells as they are born. Furthermore, zebrafish are easy to breed and develop externally, so they are very easy to handle.
We know that there are families of genes which are important to the process of making blood, but we do not completely understand how blood develops. I will begin to investigate one family of genes, called Wnt. To do so, I will determine where and when the Wnt genes turn on and turn off. The reason for this is that genes are important to regulating biological processes. In particular, Wnt genes that are expressed where blood develops, like in the embryonic artery, could be important to making blood. To determine if these genes are important to making blood, I will deactivate them in a zebrafish model and see if blood still forms.
When we confirm which Wnt genes are important for making blood in a zebrafish model, we can use this to make blood for humans. To do this, we can take a small skin sample from a patient in need of a transplant and make blood stem cells from their own cells. This would impact on the numerous Canadian patients suffering from diseases like leukemia and lymphoma.
Department
Program
CIHR Fellowship
Recipient
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
300436
Name
Grainger Stephanie L
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Wnt regulation of the hematopoietic stem cell niche
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Blood; Development; Differentiation; In Situ Hybridization; Leukemia; Niche; Stem Cell; Transgenic; Wnt; Zebrafish
Abstract
Currently, blood disorders such as leukemias and lymphomas are most easily treated with a bone marrow donation. This process is painful and the supply of donors far exceeds the demand. In fact, two-thirds of patients in need of donation do not have a match. Therefore, the ability to make blood from patient-derived stem cells would be an important advance in therapeutic technology.
Zebrafish are a particularly useful model system to watch blood form, because they are translucent and we can track the blood as it forms. In fact, we have genetic tools where we mark the blood stem cells with a fluorescent protein and we can watch the stem cells as they are born. Furthermore, zebrafish are easy to breed and develop externally, so they are very easy to handle.
We know that there are families of genes which are important to the process of making blood, but we do not completely understand how blood develops. I will begin to investigate one family of genes, called Wnt. To do so, I will determine where and when the Wnt genes turn on and turn off. The reason for this is that genes are important to regulating biological processes. In particular, Wnt genes that are expressed where blood develops, like in the embryonic artery, could be important to making blood. To determine if these genes are important to making blood, I will deactivate them in a zebrafish model and see if blood still forms.
When we confirm which Wnt genes are important for making blood in a zebrafish model, we can use this to make blood for humans. To do this, we can take a small skin sample from a patient in need of a transplant and make blood stem cells from their own cells. This would impact on the numerous Canadian patients suffering from diseases like leukemia and lymphoma.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Grainger, Stephanie L
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~